Blogs
ERP
CATEGORIES
Business Applications
Pharma & Life Sciences
oktober 22, 2026
LCS to PPAC Migration: next steps for Pharma
Microsoft is moving Dynamics 365 finance and operations environments from Lifecycle Services (LCS) to the Power Platform Admin Center (PPAC). New...
Thomas Van Dorpe
ERP
IFS
oktober 13, 2026
Getting More Value From IFS After Go-Live: Why Support and Improvement Belong in One Model
A stable IFS environment isn't automatically a valuable one. Stability covers only half the job. The other half, continuous improvement, is exactly where many...
Erik Samuelsson
ERP
IFS Cloud
oktober 12, 2026
IFS Cloud, AI and AMS: a three-fold strategy for Swedish customers
In today’s fast-evolving digital landscape, Swedish businesses are under increasing pressure to modernize their operations while maintaining stability and...
Erik Samuelsson
Business Applications
Pharma & Life Sciences
augusti 27, 2026
Why your CE mark won't get you onto the US Market
For many European medical device companies, the US represents the next growth market. The surprise comes when they discover thata CE mark, established quality...
Thomas Van Dorpe
Business Applications
Pharma & Life Sciences
augusti 27, 2026
AI in medical devices: What the FDA's predetermined change control plan actually covers
Your medical device's AI algorithm will not stay the same after it reaches the market. It will be retrained, refined, and improved, and every one of those...
Thomas Van Dorpe
Business Applications
Pharma & Life Sciences
maj 06, 2026
Why AI belongs on the Pharma C-level strategic agenda
Artificial intelligence is no longer a future technology for pharma; it is already part of the infrastructure that supports scientific progress, operational...
Thomas Van Dorpe
Business Applications
Pharma & Life Sciences
maj 06, 2026
EU GMP Annex 11 & Annex 22: The New Compliance Reality for AI in Pharma
Pharma is in the middle of its biggest regulatory shift in more than 30 years. And for the first time, regulators are directly addressing AI, with its own...
Thomas Van Dorpe
Business Applications
Pharma & Life Sciences
maj 06, 2026
What Pharma Can (and Cannot) Do with AI Under Annex 22
The business wants AI agents, the use cases look compelling, and the technology is moving faster than anyone can comfortably track, and then somewhere in the...
Thomas Van Dorpe
Business Applications
Pharma & Life Sciences
maj 06, 2026
Who Owns AI in Pharma? Why Governance Must Be Cross‑Functional
Most pharma AI initiatives do not fail because the technology does not work. They fail because no one can clearly answer a much more basic question: Who owns...
Thomas Van Dorpe
Business Applications
ERP
maj 05, 2026
Autonomous AI Agents in Dynamics 365: Your First Line of Intelligent Automation
Imagine intelligent digital colleagues that work proactively and learn from user feedback; designed to automate repetitive tasks, reduce errors and give your...
Thomas Van Dorpe